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Abstract 
Objective  
To assess the test-retest reliability of orthostatic beat-to-beat blood pressure responses to 
active standing and related clinical definitions of orthostatic hypotension.  
Methods 
A random sample of community dwelling older adults from the pan-European Survey of 
Health, Ageing and Retirement in Europe, Ireland underwent a health assessment which 
mimicked that of the Irish Longitudinal Study on Ageing. An active stand test was performed 
using continuous blood pressure measurements. Participants attended a repeat assessment 
4-12 weeks after the initial measurement. A mixed-effects regression model estimated the 
reliability and minimum detectable change while controlling for fixed observer and time of 
day effects.  
Results 
A total of 125 individuals underwent repeat assessment (mean age 66.2±7.5;55.6% women). 
Mean time between visits was 84.3±23.3 days. There was no significant mean difference in 
heart rate or blood pressure recovery variables between the first and repeat assessments. 
Minimum detectable change was noted for changes from resting values in systolic blood 
pressure(26.4mmHg) and diastolic blood pressure(13.7mmHg) at 110 seconds  and for 
changes in heart rate(10.9bpm) from resting values at 30 seconds after standing. Intra-class 
correlation values ranged from 0.47 for nadir values to 0.80 for heart rate and systolic blood 
pressure values measured 110 seconds after standing. 
Conclusion 
Continuous orthostatic beat-to-beat blood pressure and related clinical definitions show 
moderate reliability and substantial natural variation over a 4-12 week period. 
Understanding variation in measures is essential for study design or estimating the effects of 
orthostatic hypotension, while clinically it can be used when evaluating longer term 
treatment effects. 
Introduction 
Orthostatic blood pressure (BP) responses are used to identify patients with orthostatic 
hypotension who are at risk of syncope, falls and autonomic dysfunction[1]. Traditionally, 
auscultatory or oscillometric BP measurement methods have been employed[2]. Over the 
past twenty years emerging clinical and epidemiological practice has shifted towards the use 
of continuous beat-to-beat BP(CBP) measurements[3]. Impairments in CBP responses are 
related to increased levels of frailty[4], cognitive impairment[5], and falls risk[6] in cross-
sectional and longitudinal studies. 
Understanding the reliability of CBP measurements is important in all applications of these 
measures. Numerous approaches for characterising altered CBP behaviour[7] are suggested 
in the literature e.g. initial orthostatic hypotension[8], classical orthostatic hypotension 
(OH)[3], impaired BP stabilisation [9], and morphological approaches[6]. Given that 
traditional BP measurements have considerable intra- and inter-individual variability[10] and 
intra-observer effects[11] we hypothesize that CBP are similarly affected.  
Information on measurement error for CBP is important for clinical practice and research 
studies. Clinical diagnoses require repeatable and robust biomarkers with well characterised 
intra- and inter- individual variability [11], while in research, knowledge of measurement 
error is used in power calculations, to select outcome measures and to reduce errors 
associated with incomplete correction of confounding and regression dilution bias [12]. 
In this paper we focus on the medium term (4-12 weeks) reliability of active stand responses 
and related classifications of OH using CBP approaches in a population study of adults aged 
over 50 years. Bias, standard error of measurement (SEM), minimal detectable change 
(MDC) between measurements, intra-class correlation coefficients (ICC) and kappa statistics 
are reported.  
Methods 
Study population 
Participants for this study were recruited from a random sample of older adults (n≈1100) 
aged over 50 living in Ireland who previously took part in the pan-European Survey of 
Health, Ageing and Retirement in Europe (SHARE), Ireland between 2006 and 2007[15]. 
These individuals were invited to take part in a health assessment in 2011 which mimicked 
that of the Irish Longitudinal Study on Ageing (TILDA) and included an active stand test 
[13][14]. A short-form version of the TILDA computer aided personal interview (CAPI) was 
administered during this assessment to provide demographic and self-reported health and 
socioeconomic information.  
To examine the repeatability of outcome variables participants attended for a repeat health 
assessment approximately 4-12 weeks after the baseline measurement. To control for the 
effects of time-of-day and observer on the outcome variables participants were randomly 
assigned to have their health assessment performed either in the morning (AM: 9.30am) or 
afternoon (PM: 2:00pm) and to be assessed by 1 of 2 research nurses. Ethical approval was 
obtained from Trinity College Dublin ethics committee and all respondents provided signed 
informed consent prior to participation. All experimental procedures adhered to the 
Declaration of Helsinki. 
Inclusion and Exclusion Criteria 
This nationally representative sample was constructed using the RANSAM framework [14] 
using a 2-stage clustered sampling process using the Irish Geodirectory as the sampling 
frame. The Irish Geodirectory is a comprehensive listing of all addresses in the Republic of 
Ireland. These addresses were assessed for eligibility, and members of eligible households aged ≥50 
years were canvassed to participate in the study. The n≈1100 individuals that participated in the 
original SHARE study were subsequently invited to participate in the health assessment as 
described above. Patients with specific autonomic dysfunction were not excluded from the 
study, however those who lacked capacity to consent to the study or were living in 
institutional care were excluded.  
Continuous Orthostatic Blood Pressure Measurement 
CBP responses to orthostasis were measured using the volume clamp method (Finometer®, 
Finapres Medical Systems, Arnhem, The Netherlands) as previously described [16][3]. 
Measurements were performed in a quiet, temperate room (21-23oC). Participants rested in 
the supine position for 10 minutes and were then instructed to stand. Assistance to mobilise 
was provided as required. Participants stood while systolic BP (SBP), diastolic BP (DBP), and 
heart rate (HR) were monitored for 2.5 minutes with subjects reporting symptoms of 
dizziness, light-headedness or unsteadiness during the stand (coded as orthostatic 
symptoms). The measurement hand (left) was maintained by the participant’s side 
throughout the period of measurement. The height correction unit was used to correct for 
any hydrostatic offsets introduced during change of position [3,16]. The Physiocal® system 
remained on during the supine rest period and was switched off just prior to the stand. This 
identical protocol was repeated on the second health assessment visit by the assigned 
research nurse. The role of the observing research nurse was to guide participants 
throughout the protocol according to a standard operating procedure. Data analyses were 
performed independently of the observer [16]. 
Data Analysis of CBP Records 
Raw CBP data was automatically processed to reject artefacts, and perform moving average 
filtering and BP waveform feature extraction [16]. A 2-second moving average filter was 
applied to the raw CBP to allow nadir and peak CBP and HR values to be extracted with a 
high time resolution while also minimising noise. A moving average filter (+/-5 seconds 
around each reported time point) was applied to the raw CBP e.g. the filtered value at 60 
seconds is a weighted mean of the values occurring in the window from 55-65 secs. This 
data was used to capture the recovery trends as per previous work [3,16] while balancing 
noise reduction, the data set size for epidemiological samples and falls risk prediction. The 
following features were automatically extracted [3][16]: Supine SBP, DBP and HR: Values of 
SBP (SBPB), DBP (DBPB) and HR (HRB) defined as the average of supine data occurring -60 to -
30 seconds prior to standing; Systolic BP and Diastolic BP Nadirs: Minimum SBP or DBP value 
occurring within 30 seconds of standing denoted SBPNadir and DBPNadir; Peak HR: Maximum 
heart rate (HRPeak) after standing was defined given its association with ageing [3] and 
autonomic dysfunction [17]; Recovery values at specified time intervals: SBP, DBP, and HR 
values at takes on values 30, 60, 90 and 110 seconds post-stand. These values are denoted 
SBP(t), DBP(t), and HR(t) where t is time in seconds after standing; Delta values at specified 
time intervals: Change in SBP, DBP, and HR values from supine values. These values are 
denoted ΔSBP(t), ΔDBP(t), and ΔHR(t) where t is time in seconds after standing and takes on 
values 30, 60, 90 and 110 seconds; Impaired orthostatic BP stabilisation OH(t) was defined 
as failure to return to within SBP≥20mmHg and/or DBP≥10mmHg of supine levels at t 
seconds after standing where t is time in seconds after standing and takes on values 30 to 90 
seconds in 30-second intervals. An additional analysis examined the effect of including a 
modified threshold of 30mmHg SBP drop in those with supine systolic hypertension 
>160mmHg. Sustained tachycardia was defined as a sustained HR increase of >30bpm or a 
HR of 120bpm at all time points after standing.   
Participant Characteristics  
The following characteristics were recorded: age (years), gender, height (cm), body mass 
index (BMI–kg/m2), mean gait speed (cm/sec), dominant hand grip strength (kg), history of 
fractures, faints, falls, a doctor’s diagnosis of heart attack, hypertension, high cholesterol, 
stroke, diabetes, atrial fibrillation, arthritis, osteoporosis. Medication use was quantified to 
capture the number of medications taken, those on antihypertensives and polypharmacy 
(taking ≥5 medications). To assess global cognition the Montreal Cognitive Assessment 
(MOCA) was administered [18], with mental health assessed using the 8-item Centre for 
Epidemiological Studies Depression (CES-D) scale [19] [13].  
Statistical Analyses 
Analyses were performed using Stata (ver.12). Paired t-tests for continuous variables were 
applied to assess univariate mean differences across time points for each measure (See 
Table 2). For each continuous variable a linear mixed-effects model (Table 3) was estimated 
including random effect of participant and fixed effects of time-of-day, and observer effects.  
From the model the standard deviation of the between participant (SDbetween; standard 
deviation of the random effect) and within participant variation (SDwithin; residual standard 
deviation) were extracted. ICC, the proportion of variability explained by between-individual 
differences, was estimated as ICC = SDbetween
2 / (SDwithin
2 + SDbetween
2) (See Table 3). A False 
Discovery rate approach was used to control for multiple testing with a corrected 
significance level of P = 0.0015 [20] for statistical significance. Bland-Altman plots 
(Supplementary Figure 1-3) were used to estimate the mean difference between repeated 
measures (bias) and the MDC for each continuous measure. The MDC reflects the maximum 
difference between two occasions that could be attributed to chance within the same 
individual given the estimated within-person variability for each measure. MDC is estimated 
by MDC= 𝑆𝐷𝑊𝑖𝑡ℎ𝑖𝑛 × √2 × 𝑍 where 𝑍 =1.96 for the 95% MDC. The agreement across time 
points of the following binary classifications: OH, OH(t) (at all time-points t=10,20,…,110 
seconds after standing) and sustained tachycardia was reported using Cohen’s Kappa 
statistic.  
Results  
Sample  
Data from 125 participants aged 66.2±7.5 years old of whom 55.6% are women were 
available for analysis with five participants without a complete active stand dataset. 82 
(65.6%) participants were allocated a different observer (Observer 1 versus Observer 2), 
while 57 (45.6%) were assigned a different time of day (AM versus PM) for the second visit. 
The mean time between visits was 84.3±23.3 days. Participant characteristics are detailed in 
Table 1.  
Reliability of CBP Measurements 
After correcting for multiple testing, univariate analysis showed that some absolute 
measures of BP were lower at repeat compared to baseline. This, however, resulted in no 
substantial mean differences in BP recovery between the baseline and repeat measurement, 
where only a few statistical differences were found. Mean HR and HR recovery were similar 
in the baseline and repeat assessments (Table 2). We found the same results after 
multivariate analysis with time-of-day and observer as covariates (Table 3). 
Substantial within-person variation was noted across all absolute measures of SBP, DBP and 
HR. These values had (by conventional cut-offs) moderate to high repeatability with ICC 
values ranging from 0.6 to 0.8, with HR more reliable than BP values.  
The repeatability of the baseline corrected parameters were lower, with similar magnitudes 
of variation within and between individuals leading to moderate ICC values ranging of 0.4-
0.7. 
The MDC for absolute SBP ranged from 32.7mmHg to 39.4mmHg. The MDC values for 
absolute DBP are smaller and ranged from 15.9mmHg at 110 seconds after standing to 
20.2mmHg at the nadir. HR MDC values ranged from 12.7bpm to 16.7bpm. MDC values for 
values corrected for supine resting values were marginally improved (Table 3). Figures 1-3 
depict the Bland-Altman plots for these relationships.  
Reliability of Orthostatic Hypotension and Related Classifications 
Classical OH (κ=0.21;P=0.009), OH(t) demonstrated low to moderate agreement across 
repeated measurements with the reliability of OH(t) highest at 50 seconds after standing 
(κ=0.40;P<0.0001) (Table 4). For example, although 16 out of 125 participants were classified 
at both the baseline assessment and at the repeat, only 5 of these were classified with OH 
on both occasions.  
Additional analysis indicated that the reliability of OH definition was not sensitive to the 
effect of changing the diagnostic threshold to 30mmHg in those with supine hypertension 
>160mmHg. 
Discussion  
Continuous BP and HR measurements (and commonly derived clinical measures e.g. OH) 
during standing have low to moderate levels of reliability (ICC=0.46-0.80 for continuous 
measures, κ=0.21–0.40 for binary classifications) and MDC over a 4-12 week period. While 
many absolute BP measures were lower during the repeat visit, there was less systematic 
difference in measures of BP recovery. 
The mean values of SBP, DBP, HR, ∆SBP, ∆DBP, ∆HR are relatively stable across a 4-12 week 
period. HR values are the most reliable with DBP being the least reliable. From the Bland-
Altman plots (Supplementary Figure) it is evident that the MDC are wide and range from 25-
40mmHg for SBP/∆SBP, 11-16mmHg for DBP/∆DBP and 12-16bpm for HR/∆HR measures.  
Clinicians should be aware of the MDC in these measures when assessing the effect of 
interventions or the progression of patients. Owing to the natural variation and day-to-day 
changes in factors that affect BP, 95% of patients would be expected to exhibit changes 
within the 95% MDC by chance alone when two measures taken at different times are 
compared. 
From a research perspective, knowledge of between and within-person variability will assist 
in performing power calculations, and reducing bias associated with misclassified exposure 
(otherwise called predictor or independent variables) or confounding variables. Regression 
dilution bias occurs when exposure variables are measured with error, and causes 
underestimation of effects. This bias can be corrected using the reliability information we 
report here [12]. The degree of dilution is determined by the reliability of the exposure 
measurement, given here by ICC ranging from 0 to 1. For example an uncorrected estimate, 
β=-0.15, of the association between increasing ΔSBP(30) and measures of global cognition is 
biased downwards if an unreliable measurement of ΔSBP(30) is used.  This can be corrected 
by applying the correction formula βcorrected=β/ICC. This gives a corrected coefficient of 
βcorrected=-0.25, where ICC=0.59 is reported in Table 3.  Our findings are therefore important 
to those estimating the effects of impaired BP recovery on future health outcomes. More 
generally, measurement error in confounding variables can also lead to false positive effects, 
because confounding control for such variables will be incomplete if unreliable measures are 
used.  Procedures such as errors-in-variables regression can produce unbiased estimates, 
but rely on knowing the reliability or the within-person standard deviation to correct these 
effects. Hence our estimates are also important to those using such measures as 
confounding variables [12]. 
The reported variability here is comparable to previous reports of autonomic function and 
BP measures [21,22] and is likely physiological in origin [23]. It is well-known that SBP, DBP 
and HR fluctuate considerably over a broad range of time scales i.e. diurnal to seasonal  
[10][24]. These fluctuations are thought to arise from internal and external sources including 
changes in neurohormonal activity [25], circulating volume [26], changes in sympathetic and 
parasympathetic activity [8], and environmental effects [11]. Furthermore the active stand 
response is under the influence of a number of additional factors including self-selected 
speed of standing, muscle pump activation [27], movement artefact [16], time of day [28] 
and other experiment effects (e.g. observer) which are likely to further effect the 
repeatability of measurements. Previous studies have noted that orthostatic BP 
measurements have relatively poor reproducibility [29][30], with the reproducibility thought 
to be higher in those with neurogenic OH[31]. Others have also noted low levels of 
agreement in OH definitions (kappa 0.17–0.32) based on active stands performed at the 
same time on different days [32], suggesting that at least in this relatively healthy 
population, OH can be transient for a numbers of people. 
Strengths and Limitations 
A number of limitations are worth noting in our study. Underlying physiological changes e.g. 
hydration status over a 4-12 week period may have occurred, which may account for some 
of the within individual variability detected. No restrictions were placed on participants in 
terms of exercise, food intake, medications all of which may contribute to measurement 
variability. Repeating this study over a shorter-time frame in a more controlled environment, 
with the inclusion of same day repeated measurements could lead to higher estimates of 
reliability, but our findings reflect the variation likely to be observed in real world settings. 
The presence of orthostatic symptoms was noted however the severity and type was not 
quantified nor was the reliability of initial orthostatic hypotension since [33]. Although we 
recognise the duration of the stand was shorter than advised by AAS consensus criteria, this 
was for a number of reasons: the challenges of a large epidemiological study require a trade-
off between sample representativeness and length of time to conduct individual tests; based 
on an initial pilot study 95% of the population had recovered by 120 seconds; the duration 
of the data reported (110 seconds) was chosen to minimise missing data and end effects 
which influence the moving average filtering process [3].  
This study has a number of significant strengths. A community representative sample was 
studied allowing our results to be generalised to community dwelling individuals. Given the 
prevalence of OH (12.8%), sustained tachycardia on standing (5.6%) and diabetes (6.4%) in 
this sample, it is also captures those with autonomic dysfunction. A dedicated sample would 
be required to focus on specific autonomic disorders e.g. diabetic autonomic neuropathy. 
However our findings suggest that within-person standard deviation is not linked to absolute 
values of BP recovery, and so there is no evidence that our estimates of within-person 
standard deviation would not be applicable in this group although it would be interesting to 
examine these relationships in individuals with type 2 diabetes or hypertension [34]. A 
comprehensive battery of physical, cognitive and mental health measures was obtained, 
alongside socioeconomic and health utilisation metrics. All measures were collected using 
internationally standardised protocols.  
Conclusion 
Continuous BP and HR measurements and related clinical definitions of OH during standing 
show moderate reliability and substantial natural variation over a 4-12 week period. 
Understanding variation in measures is essential for researchers designing studies or 
estimating the effects of OH, while in clinical settings reliability statistics should be 
considered when evaluating longer term treatment effects.  
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Table 1: Cohort characteristics. 
Age (Years), Mean (SD) 66.2 ±7.5  
Gender (Male), % (N) 44.4 ±55 
Height (cm), Mean (SD) 165.3 ± 10.2   
Body Mass Index (kg/m2), Mean (SD) 28.3 ± 4.1 
Cardiovascular Conditions  
Heart Attack, % (N) 6.4 (8) 
Hypertension, % (N) 39.2 (49) 
High Cholesterol, % (N)  55.2 (69) 
Stroke, % (N) 4.0 (5) 
Diabetes, % (N) 6.4 (8) 
Atrial Fibrillation, % (N) 2.4 (3) 
Other Relevant Medical History  
Arthritis, % (N) 27.2 (34) 
Osteoporosis, % (N) 14.4 (18) 
History of Fractures, % (N) 16.0 (20) 
History of Falls, % (N) 4.8 (6) 
History of Fainting, % (N) 7.2 (9) 
Orthostatic Symptoms, % (N) 25.6 (32) 
Physical Health measures  
CES-D, Mean (SD)   4.3 ±3.8 
MOCA, Mean (SD) 24.9 ±3.6 
Gait speed (cm/sec), Mean (SD) 138 ±20.3 
Grip strength dominant hand (kg), Mean (SD) 31.5 ±10.7 
Medication Use  
Polypharmacy, % (N) 40.0 (50)  
Antihypertensives, % (N) 41.6 (52) 
Number of Medications, % (N) 4.3 (2.7) 
Cardiovascular Response to Standing  
Classical Orthostatic Hypotension (OH), % (N)  12.8 (16) 
Impaired orthostatic BP stabilisation, OH(40), % (N) 20.8 (26) 
Sustained Tachycardia after Standing >30bpm or >120bpm
a
,
 
% (N) 5.6 (7) 
Sustained Tachycardia after Standing >30bpm or >120bpm without OH
b
, % (N) 0 (0)  
Table 1. Cohort characteristics. History of fractures = ever fractured a hip, wrist or other bone; History of Falls = 1 or more 
falls in the past year; History of Syncope = 1 or more faints in the last year; MOCA Score= Montreal Cognitive Assessment; 
CES-D = Centre of Epidemiological Studies Depression Scale; BP = blood pressure; HR = heart rate; bpm = beats per minute. 
Sample size = 125. OH(40) = impaired blood pressure stabilisation defined as a drop of 20/10mmHg at 40 seconds after 
standing. OH = Orthostatic hypotension was defined as sustained failure of SBP or DBP to stabilise to within 20mmHg SBP 
or 10mmHg DBP of supine levels throughout the active stand from 60 to 110s after standing. 
a 
= no participants satisfied 
the >120bpm criteria. 
b 
= no participants satisfied both suatined tachycardia and sustained OH. 
 
 
 
 
 
Table 2: Univariate Repeatability of Active Stand Variables 
Variable Baseline Repeat Variable Baseline Repeat 
Supine SBP  143.3 ±23.4 140.9 ±21.5* - - - 
Supine DBP 74.1 ±9.2 73.5 ±8.6 - - - 
Supine HR 65.5 ±9.3 64.8 ±9.5 - - - 
SBP Nadir 108.9 ±22.3 104.0 ±22.1*** ΔSBPNadir 34.4 ±15.7 36.9 ±16.6* 
DBP Nadir 55.4 ±11.6 52.9 ±10.8*** ΔDBPNadir 18.7 ±9.2 20.5 ±9.1* 
HR Peak 84.3 ±12.0 83.5 ±11.7 ΔHRPeak 18.8 ±7.4 18.7 ±7.9 
SBP(30) 140.6 ±23.6 135.5 ±24.6*** ΔSBP(30) 2.8 ±16.2 5.4 ±17.1* 
DBP(30) 75.2 ±10.9 72.9 ±10.3** ΔDBP(30) -1.1 ±7.7 0.5 ±8.4* 
HR(30) 72.0 ±12.1 71.8 ±11.8 ΔHR(30) 6.5 ±6.1 7.0 ±5.6 
SBP(60) 138.9 ±24.3 134.3 ±25.8** ΔSBP(60) 4.4 ±17.0 6.6 ±17.5 
DBP(60) 75.0 ±11.0 72.6 ±11.0** ΔDBP(60) -0.9 ±7.6 0.8 ±8.3 
HR(60) 73.3 ±11.7 73.2 ±11.1 ΔHR(60) 7.7 ±6.6 8.4 ±5.9 
SBP(90) 141.8 ±23.8 137.6 ±25.0** ΔSBP(90) 1.5 ±16.1 3.3 ±15.5 
DBP(90) 76.3 ±11.0 73.9 ±10.6** ΔDBP(90) -2.2 ±7.1 -0.5 ±7.7* 
HR(90) 72.7 ±11.9 73.4 ±10.8 ΔHR(90) 7.1 ±6.5 8.6 ±6.0 
SBP(110) 141.3 ±24.5 137.9 ±24.6** ΔSBP(110) 2.0 ±16.2 2.9 ±15.6 
DBP(110) 75.8 ±11.0 74.2 ±10.3* ΔDBP(110) -1.8 ±7.1 -0.7 ±7.5 
HR(110) 73.1 ±11.7 73.1 ±11.1 ΔHR(110) 7.5 ±6.4 8.2 ±5.9 
Table 2: Univariate analysis of active stand variables reliability. Mean and standard deviation (SD) displayed. P value results 
from paired t-test of difference between means. All blood pressure values are reported in mmHg and heart rate values in 
beats per minute (bpm). SBP(t) = systolic BP at time t; DBP(t) = diastolic BP at time t; HR(t) = HR at time t. Δ = values 
corrected for resting values. * = P≤0.05; **=P≤0.01;*** P≤0.0015. 
  
Table 3: Multivariate Reliability Statistics of Active Stand Variables 
 Baseline vs Repeat Reliability Statistics  Baseline vs Repeat Reliability Statistics 
Variable Diff. means P Value 
SD 
(Between 
partipants) 
SD (Within 
participants) ICC MDC Variable 
Diff. 
means P Value 
SD 
(Between 
partipants) 
SD (Within 
participants) ICC MDC 
Supine SBP 3.0 0.069 18.6 12.3 0.70 34.1 - - - - - - - 
Supine DBP 0.7 0.340 6.6 5.8 0.57 16.0 - - - - - - - 
Supine HR 0.3 0.594 8.2 4.6 0.76 12.7 - - - - - - - 
SBP Nadir 5.3 0.003** 17.7 13.2 0.64 36.7 ΔSBPNadir -2.4 0.080 12.4 10.2 0.64 28.2 
DBP Nadir 2.5 0.010** 8.4 7.3 0.57 20.2 ΔDBPNadir -1.7 0.058 5.8 7.0 0.57 19.3 
HR Peak 0.7 0.310 10.6 5.4 0.80 14.9 ΔHRPeak -0.4 0.488 6.5 4.1 0.80 11.5 
SBP(30) 5.4 0.002** 19.9 13.2 0.70 36.6 ΔSBP(30) -2.4 0.082 12.6 10.5 0.60 29.1 
DBP(30) 2.4 0.002** 8.6 6.0 0.67 16.7 ΔDBP(30) -1.7 0.035* 5.4 5.9 0.41 16.5 
HR(30) -0.1 0.878 10.4 5.7 0.77 15.9 ΔHR(30) 0.4 0.421 4.2 3.9 0.71 10.9 
SBP(60) 5.0 0.008** 20.4 14.2 0.67 39.4 ΔSBP(60) -2.0 0.179 12.9 11.1 0.59 30.9 
DBP(60) 2.5 0.003** 8.9 6.2 0.67 17.3 ΔDBP(60) -1.7 0.018* 5.6 5.5 0.45 15.4 
HR(60) -0.1 0.937 9.6 6.0 0.72 16.7 ΔHR(60) 0.4 0.482 4.3 4.4 0.54 12.1 
SBP(90) 4.7 0.005** 20.8 12.6 0.73 34.8 ΔSBP(90) -1.7 0.243 11.4 10.7 0.57 29.5 
DBP(90) 2.5 0.003** 8.6 6.3 0.65 17.4 ΔDBP(90) -1.8 0.013* 5.0 5.4 0.51 15.0 
HR(90) -0.9 0.216 9.9 5.4 0.77 15.0 ΔHR(90) 1.2 0.030* 4.5 4.2 0.50 11.6 
SBP(110) 4.0 0.012* 21.4 11.8 0.77 32.7 ΔSBP(110) -0.9 0.481 12.5 9.5 0.54 26.4 
DBP(110) 1.8 0.016* 8.8 5.7 0.70 15.9 ΔDBP(110) -1.1 0.094 5.3 4.9 0.46 13.7 
HR(110) -0.3 0.720 10.0 5.4 0.77 15.0 ΔHR(110) 0.6 0.296 4.4 4.1 0.54 11.4 
              
Multivariate Reliability Statistics of Active Stand Variables. Reliability summary statistics are also detailed where SD(Between participants) is the standard deviation between individuals, 
SD(Within participants) is the standard deviation within individuals, ICC is the intraclass correlation coefficient and MDC is the minimal detectable change . SBP(t) = systolic BP at time t; DBP(t) 
= diastolic BP at time t; HR(t) = HR at time t. Δ = values corrected for resting values. Diff. means = baseline-repeat measurements. All values are adjusted for rate and time of day effects. * = 
P≤0.05; **=P≤0.01;*** P≤0.0015.  
 
 
  
 
Table 4: Reliability of Orthostatic Hypotension and Postural Tachycardia Definitions 
 
OH 
 
OH(50) 
 
Sustained Tachycardia    
 Baseline   Baseline   Baseline 
  
OH - OH + 
  
OH(50) -  OH(50) +  
  
PT -  PT + 
Repeat 
OH -  98 11 
 
OH(50) - 83 12 
 
PT - 110 9 
OH +  11 5 
 
OH(50) + 14 15 
 
PT + 5 1 
  
κ  = 0.21 P=0.009 
  
κ = 0.40 P=0.0000 
  
κ = 0.069 P=0.21 
Table 4: Reliability of Orthostatic Hypotension (and variants) and Postural Tachycardia definitions. Legend: κ = Cohen’s Kappa coefficient. OH = Orthostatic hypotension was defined as 
sustained failure of SBP or DBP to stabilise to within 20mmHg SBP or 10mmHg DBP of supine levels throughout the active stand from 60 to 110s after standing. OH(50) = impaired blood 
pressure stabilisation defined as a drop of 20/10mmHg at 50 seconds after standing. Sustained Tachycardia = sustained HR increase of >30bpm or a HR of >120bpm after standing.  
 
 
 
 
 
 
 
 
 
 
 
